Retinopathy of Prematurity Reactivated 28 Months after Injection of Ranibizumab-Reference-Cited by-同舟云学术

Retinopathy of Prematurity Reactivated 28 Months after Injection of Ranibizumab

Published:2019-10 Issue:10 Volume:3 Page:913-915
ISSN:2468-6530
Container-title:Ophthalmology Retina
language:en
Short-container-title:Ophthalmology Retina

Author:

Ji Marco H.,Moshfeghi Darius M.,Callaway Natalia F.^ORCID,Bodnar Zachary,Schachar Ira H.^ORCID,Amorelli Giulia M.^ORCID,Orazi Lorenzo,Molle Fernando,Lepore Domenico

Funder

Heed Ophthalmic Foundation

Publisher

Elsevier BV

Subject

Ophthalmology

Reference7 articles.

1. Reactivation of retinopathy of prematurity three years after treatment with bevacizumab;Hajrasouliha;Ophthalmic Surg Lasers Imaging Retina,2017

2. A Spectrum of regression following intravitreal bevacizumab in retinopathy of prematurity;Chen;Am J Ophthalmol,2019

3. Follow-up to age 4 years of treatment of type 1 retinopathy of prematurity intravitreal bevacizumab injection versus laser: fluorescein angiographic findings;Lepore;Ophthalmology,2017

4. Chronic vascular arrest as a predictor of bevacizumab treatment failure in retinopathy of prematurity;Toy;Ophthalmology,2016

5. Anti-VEGF antibody leads to later atypical intravitreous neovascularization and activation of angiogenic pathways in a rat model of retinopathy of prematurity;McCloskey;Invest Ophthalmol Vis Sci,2013

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retinopathy of prematurity risk predictors in peripheral avascular retina after intravitreal ranibizumab treatment: Vasculogenesis analysis Running Title: Predictors for Retinopathy Recurrence Post-Ranibizumab;2023-11-03

2. RATE OF AND TIME TO COMPLETE RETINAL VASCULARIZATION IN PREMATURE INFANTS AND ASSOCIATED FACTORS;Retina;2023-01

3. Retinopathy of prematurity risk predictors in peripheral avascular areas after intravitreal ranibizumab treatment: Vascular outgrowth speed analysis;2022-10-06

4. Complications of retinopathy of prematurity treatment;Current Opinion in Ophthalmology;2021-07-06

5. Conserved regression patterns of retinopathy of prematurity after intravitreal ranibizumab: A class effect;European Journal of Ophthalmology;2020-07-28